Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Warns Against Donations of Drug Products

This article was originally published in PharmAsia News

Executive Summary

China issued a new warning against violations of its strict ban on donations of pharmaceutical products. A State FDA spokeswoman said the ban on donations extends even to drugs and equipment that have been approved only for clinical trials. Generally, the ban on donations covers drugs without SFDA approval and foreign drugs that do not have the approval of the country of origin. Even for legal drugs, the spokeswoman said, the only organizations eligible to accept donations are provincial or state civil affairs and health departments, the Red Cross Society and the China Charity Federation. (Click here for more

China issued a new warning against violations of its strict ban on donations of pharmaceutical products. A State FDA spokeswoman said the ban on donations extends even to drugs and equipment that have been approved only for clinical trials. Generally, the ban on donations covers drugs without SFDA approval and foreign drugs that do not have the approval of the country of origin. Even for legal drugs, the spokeswoman said, the only organizations eligible to accept donations are provincial or state civil affairs and health departments, the Red Cross Society and the China Charity Federation. (Click here for more )

"SFDA Outlines Rules For Drug, Medical Equipment Donations" - (People's Daily) (China) (2/3/08)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067792

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel